58 results on '"Fleischmann J"'
Search Results
2. Micromechanical Modeling of Yield in Isotropic Non-Cohesive Particulate Materials
3. Fetales Steißbeinteratom – eine Gegenüberstellung zweier Fallberichte
4. Emission spectroscopy of nitric oxide in laser-induced plasma
5. Prevalence and Treatment of Chronic Lymphocytic Leukaemia (Cll) In Germany: An Analysis of Sickness Funds
6. Determination of Yield Surfaces for Isotropic Non-Cohesive Particulate Materials by the Discrete Element Method
7. Cost-Effectiveness of Early Versus Delayed Hepatitis C Virus (HCV) Treatment with Telaprevir/Pegylated Interferon Alpha/Ribavirin Triple Therapy in Adults Aged 40+ in France
8. Cost-Effectiveness of Hepatitis C Virus (HCV) Treatment with Telaprevir/Pegylated Interferon Alpha/Ribavirin Triple Therapy Versus Waiting for New Regimens in France
9. Knee and Hip Joint Biomechanics are Gender-specific in Runners with High Running Mileage
10. Quantitative Comparison of Two-Dimensional and Three-Dimensional Discrete-Element Simulations of Nominally Two-Dimensional Shear Flow
11. PCN2 Data Analyses on Prevalence and Treatment of Acute Myeloid Leukaemia in Germany
12. PIN62 Cost-Effectiveness of Triple Therapy With Telaprevir for the Treatment of Treatment-Naïve Genotype 1 Chronic Hepatitis C Patients in Germany
13. Sekundärdatenanalyse zur Prävalenz und Therapie der akuten myeloischen Leukämie in Deutschland
14. Die Kosteneffektivität von Telaprevir (TVR) in Kombination mit pegyliertem Interferon-alfa und Ribavirin (PR) zur Behandlung von Patienten mit chronischer Hepatitis C vom Genotyp1
15. PIN42 The Cost-Effectiveness of Telaprevir (TVR) in Combination With Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1(G1) Chronic Hepatitis C Patients: A Post-Hoc Analysis of Il-28B Subgroup
16. PIN27 The Cost-Effectiveness of Telaprevir (TVR) in Combination With Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1(G1) Chronic Hepatitis C Patients
17. 1102 THE COST-EFFECTIVENESS OF TELAPREVIR (TVR) IN COMBINATION WITH PEGYLATED INTERFERON-ALFA AND RIBAVIRIN (PR) FOR THE TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS
18. PIN108 Sustained Virological Response as Patient-Relevant Endpoint in Hepatitis C?
19. PMH6 Effectiveness of Long-Acting Iinjectable Risperidone and Oral Atypical Antipsychotics in a 24-Months Observational Study in Adult Patients with Schizophrenia in Germany
20. PIN55 RISK SCORES PREDICTING RESOURCE USE OF HEPATITIS C PATIENTS IN GERMANY—AN ANALYSIS OF SICK FUND CLAIMS DATA
21. PSY8 BUDGET IMPACT OF THE USE OF HYDROMORPHONE ONCE DAILY IN CHRONIC PAIN PATIENTS IN THE GERMAN HEALTH CARE SYSTEM—AN UPDATE
22. PMH20 IMPACT AND COSTS OF HOSPITALIZATION IN SCHIZOPHRENIA
23. PMH69 INFLUENCE OF WAITING TIME IN A LOCAL MENTAL HEALTH CARE SYSTEM IN GERMANY FOR CARE IN PATIENTS DIAGNOSED WITH SCHIZOPHRENIA OR DEPRESSION
24. PMH68 TREATMENT DISCONTINUATION IN A LOCAL MENTAL HEALTH CARE SYSTEM IN GERMANY FROM THE PATIENTS' AND HEALTH CARE PROVIDERS' PERSPECTIVE
25. PMH12 THE COMPARATIVE EFFICACY OF INJECTABLE AND ORAL ATYPICAL ANTIPSYCHOTICS IN REDUCING RELAPSES IN ADULT SCHIZOPHRENIA PATIENTS: A SYSTEMATIC REVIEW AND MIXED TREATMENT COMPARISON ANALYSIS
26. PMH22 BUDGET IMPACT OF THE USE OF RISPERIDONE LONG ACTING INJECTABLE IN THE GERMAN HEALTH CARE SYSTEM
27. Prevalence of smell loss in Parkinson's disease – A multicenter study
28. PSY36 EUROPEAN ECONOMIC EVALUATION OF OROS® HYDROMORPHONE IN THE MANAGEMENT OF SEVERE CHRONIC CANCER AND NON-CANCER PAIN
29. PSY9 BUDGET IMPACT OF THE USE OF OROS® HYDROMORPHONE ONCE DAILY IN SEVERE CHRONIC PAIN PATIENTS IN THE GERMAN HEALTH CARE SYSTEM
30. PAR5 MODELING THE ECONOMIC AND HEALTH CONSEQUENCES OF MANAGING CHRONIC OSTEOARTHRITIS PAIN WITH ORAL OPIOIDS IN GERMANY
31. Three-Dimensional Finite Element Modeling of Hard Turning Processes
32. Prototyping networked embedded systems
33. Gender differences in the severity of adult familial dyslexia
34. The effects of human immunodeficiency virus infection on macrophage phagocytosis of Candida
35. Marketing CT and MR imaging services in a large urban teaching hospital.
36. Different Modulation of the Perioperative Stress Hormone Response Under Neurolept-Anaesthesia or Enflurane for Cholecystectomy
37. Human immunodeficiency virus causes mononuclear phagocyte dysfunction.
38. Isolation of Cryptococcus neoformans gattii from a Patient with AIDS in Southern California
39. The Intracellular Fate of Histoplasma capsulatum in Human Macrophages Is Unaffected by Recombinant Human Interferon-
40. Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils
41. The injection molding of thermosets
42. Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils
43. Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients.
44. The DNA content of nongerminative variants ofCandida albicans
45. Urinary Interleukin-2 Inhibition in Patients with Cystitis
46. Increased content of microbicidal cationic peptides in rabbit alveolar macrophages elicited by complete Freund adjuvant
47. Measurement of Serum Interleukin-2 Activity
48. Antibacterial activity of microbicidal cationic proteins 1 and 2, natural peptide antibiotics of rabbit lung macrophages
49. Present-Day Large Steam-Turbine-Generator Design Practice
50. Discussion: “Operation of Steam Turbines to Minimize Shell Cracking” (Coulter, S. B., and Jackson, R. L., 1960, ASME J. Eng. Power, 82, pp. 227–238)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.